التاريخ:	--/--/-- --:--:--
مُعرِّف الحدث:	E5KVF4DES
نوع الإجراء:	ACQUISITION
حالة الإجراء:	ANNOUNCED
رمز سهم الشركة المستحوِذة:
الرمز المُستهدَف:	CNTA
مُحدَّث:	--/--/-- --:--:--
سعر شراء السهم:	38
عملة سعر السهم الواحد:	USD
مصادر الأخبار:	https://www.prnewswire.com/news-releases/lilly-to-acquire-centessa-pharmaceuticals-to-advance-treatments-for-sleep-wake-disorders-302729846.html

ملاحظات حول الإجراء

Eli Lilly and Company (NYSE: LLY) and Centessa Pharmaceuticals plc (Nasdaq: CNTA), a clinical-stage company developing a new class of medicines for the treatment of excessive daytime sleepiness and other neurological conditions, today announced a definitive agreement for Lilly to acquire Centessa. Under the terms of the transaction agreement, Lilly will acquire all of the issued and to be issued share capital of Centessa (including the American Depositary Shares (ADSs) representing ordinary shares) for $38.00 in cash per share . The transaction, which will be effectuated by way of a scheme of arrangement under the laws of England and Wales, is expected to close in the third quarter, subject to approval by Centessa shareholders, sanction by the High Court of Justice of England and Wales and satisfaction of other customary closing conditions, including regulatory approvals.